Psiloxylon mauritianum

Psiloxylon mauritianum · Accepted scientific name

Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆

Psiloxylon mauritianum is a plant species that holds significant potential in pharmacological research due to its diverse biological activities. Studies on its leaf preparations, including aqueous extracts, decoctions, and polyphenol-rich extracts, have demonstrated potent antibacterial, antioxidant, and hypolipidemic properties. A key chemical constituent identified in these extracts is gallic acid, which contributes to the plant's medicinal efficacy. These bioactive compounds show promise in addressing various health conditions such as inflammation, hyperglycemia, and liver steatosis. Furthermore, the plant demonstrates effectiveness against challenging pathogens like Methicillin-Resistant Staphylococcus aureus.

Quick facts
Synonyms
Fropiera Mauritiana
Common names
Not available
Family
Myrtaceae
Distribution
Not available
Plant Parts
Leaf

Classification

Common Names

Psiloxylon mauritianum is a notable species known by several distinct local names across its habitat. It is frequently referred to as Bois de gouyave marron or Bois de pêche marron, reflecting its unique characteristics. Some residents also call it Bois sans écorce or Bois à gratter, highlighting different physical aspects of the plant. Additionally, it is recognized by the specific designation Psiloxylon de Maurice. These various common names underscore the deep cultural and linguistic connections associated with this particular flora.

Sources: Catalogue of Life (COL)

Synonyms

Psiloxylon mauritianum is a botanical taxon that is recognized in scientific literature under a different name. It is formally identified as a synonym of Fropiera mauritiana, meaning both names refer to the same species. This nomenclatural link is essential for researchers seeking to maintain consistency in biological databases. Understanding these taxonomic relationships ensures that botanical studies remain accurate across different historical records. Consequently, navigating these synonymous labels is a key step in the precise identification of this plant.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Psiloxylon mauritianum is a specialized organism belonging to the diverse kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. The species is further organized into the order Myrtales, which defines its evolutionary lineage. It specifically holds a place within the genus Psiloxylon, a designation that highlights its unique morphological traits. Ultimately, this plant is recognized as a member of the Myrtaceae family, connecting it to a wide array of related botanical species.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Myrtales
Family Myrtaceae
Genus Psiloxylon

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Psiloxylon mauritianum is a botanical species with a specific geographical range spanning several key regions. Its distribution is primarily centered within Africa and the surrounding waters of the Western Indian Ocean. Within this maritime zone, the plant can be found established on the island of Mauritius. Additionally, its presence extends to the nearby island of Réunion, marking a distinct part of its ecological footprint. These locations highlight the specialized habitat required for this particular species to thrive.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Psiloxylon mauritianum is a self-supporting plant that maintains its own structural integrity without the need for external support.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Psiloxylon mauritianum is an endemic medicinal plant from Reunion Island that possesses a diverse range of therapeutic properties. Research has identified that the plant exhibits potent antibacterial activity, specifically through compounds like Aspidin VB which can target methicillin-resistant Staphylococcus aureus. Beyond its antimicrobial capabilities, the plant's aqueous extracts demonstrate significant antioxidant capacity by protecting cells against oxidative stress. Furthermore, the species is traditionally recognized for its hypolipidemic effects, contributing to its use in managing metabolic health. Together, these biological activities highlight the significant medicinal potential of this unique plant species.

Compounds

Psiloxylon mauritianum is an endemic medicinal plant from Reunion Island that has gained significant scientific interest for its potential to combat metabolic disorders. Recent studies utilizing liquid chromatography have confirmed that an aqueous extract of this plant is particularly rich in gallic acid. Beyond its gallic acid content, the extract also contains beneficial compounds such as caffeoylquinic acid, kaempferol, and quercetin. When tested in zebrafish models, the extract demonstrated impressive lipid-lowering properties and helped prevent body weight gain. Ultimately, these findings suggest that the plant may play a vital role in mitigating the peripheral and central deleterious effects associated with obesity.

Conditions

Psiloxylon mauritianum demonstrates significant therapeutic potential by acting as an "anti-diabetic" agent and providing "anti-weight-gain" properties through the prevention of body weight gain and hyperglycemia. Research indicates that this plant can effectively treat obesity by exhibiting lipid-lowering effects and mitigating its deleterious peripheral and central impacts. Furthermore, its polyphenol-rich extracts serve to treat Dengue and Zika virus infections by inhibiting the early stages of viral attachment to host cells. The plant also provides a potent defense against bacteria, specifically showing strong antibacterial activity to treat S. aureus, including methicillin-resistant strains. Together, these diverse biological activities highlight the medicinal versatility of this endemic species.

Preparations

Psiloxylon mauritianum is prepared as an aqueous extract, which has been shown to prevent obesity and its associated deleterious effects in zebrafish models. This plant is also prepared as a polyphenol-rich extract that demonstrates significant potential in inhibiting the early stages of Zika and Dengue virus infections. Research further indicates that aqueous extracts of this species contain high levels of gallic acid and other bioactive compounds. Additionally, the plant is traditionally prepared as decoctions and infusions to utilize its medicinal properties. Ultimately, various forms of the Psiloxylon mauritianum extract are studied for their therapeutic roles in managing metabolic disorders and viral pathogens.

Parts used

Psiloxylon mauritianum is an endemic medicinal plant native to Reunion Island that holds significant pharmacological potential. Recent chemical investigations into this species have focused on identifying bioactive compounds to combat antibiotic-resistant bacteria. Researchers successfully isolated specific phloroglucinol derivatives, known as Aspidin VB and Aspidin BB, from the leaves of the plant. Notably, the Aspidin VB compound derived from these leaves demonstrated potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Because it shows no cytotoxicity to human cells, this plant component serves as a promising natural lead for future drug development.